Risk factor
Low price volatility
Profitability factor
Strong margins and returns
About
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs,...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, reasonably
Target Price
The average target price of VETO.PA is 96 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell